115 related articles for article (PubMed ID: 37615350)
1. Glycyrrhizic Acid-Lipid Framework Nanovehicle Loading Triptolide for Combined Immunochemotherapy.
Xu Z; Huang Y; Wu Y; Chen J; Seto SW; Leung GP; Cai Y; Li J; Zhang J
ACS Appl Mater Interfaces; 2023 Sep; 15(35):41337-41350. PubMed ID: 37615350
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
3. Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy.
Yu L; Wang Z; Mo Z; Zou B; Yang Y; Sun R; Ma W; Yu M; Zhang S; Yu Z
Acta Pharm Sin B; 2021 Jul; 11(7):2004-2015. PubMed ID: 34386334
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma.
Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL
Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548
[TBL] [Abstract][Full Text] [Related]
6. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis.
Zhang W; Lu C; Liu Z; Yang D; Chen S; Cha A; Wu Z; Lu A
Planta Med; 2007 Apr; 73(4):336-40. PubMed ID: 17354165
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats.
Tai T; Huang X; Su Y; Ji J; Su Y; Jiang Z; Zhang L
J Ethnopharmacol; 2014 Mar; 152(2):358-63. PubMed ID: 24486211
[TBL] [Abstract][Full Text] [Related]
10. Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects.
Zhao X; Yang Y; Su X; Xie Y; Liang Y; Zhou T; Wu Y; Di L
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893242
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
12. Strategy for osteoarthritis therapy: Improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays.
Zhou P; Chen C; Yue X; Zhang J; Huang C; Zhao S; Wu A; Li X; Qu Y; Zhang C
Int J Pharm; 2021 Nov; 609():121211. PubMed ID: 34687817
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells.
Ochi MM; Amoabediny G; Rezayat SM; Akbarzadeh A; Ebrahimi B
Cell J; 2016; 18(2):135-48. PubMed ID: 27540518
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
15. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma.
Yin X; Xiao Y; Han L; Zhang B; Wang T; Su Z; Zhang N
AAPS PharmSciTech; 2018 Jul; 19(5):2133-2143. PubMed ID: 29714002
[TBL] [Abstract][Full Text] [Related]
16. Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer.
Zhang L; Zhang S; Jiang M; Lu L; Ding Y; Ma N; Zhao Y; Xuchen S; Zhang N
Int J Nanomedicine; 2021; 16():5531-5550. PubMed ID: 34429598
[TBL] [Abstract][Full Text] [Related]
17. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.
Li Z; Yang G; Han L; Wang R; Gong C; Yuan Y
J Nanobiotechnology; 2021 Nov; 19(1):360. PubMed ID: 34749742
[TBL] [Abstract][Full Text] [Related]
19. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
20. Triptolide Reduces Neoplastic Progression in Hepatocellular Carcinoma by Downregulating the Lipid Lipase Signaling Pathway.
Chang W; Wang J; You Y; Wang H; Xu S; Vulcano S; Xu C; Shen C; Li Z; Wang J
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
